In silico identification of natural Alzheimer inhibitors targeting GSK-3β using receptor-based pharmacophore and molecular modeling studies. International Journal of Pharmaceutical Drug Design, [S. l.], v. 2, n. 5, p. 102–107, 2025. DOI: 10.62896/ijpdd.2.5.11. Disponível em: https://ijpdd.org/index.php/files/article/view/278.. Acesso em: 2 jul. 2025.